Status:
COMPLETED
Pharmacogenetic Variation: Factors That May Affect the Efficacy and Safety of Medical Marijuana
Lead Sponsor:
Columbia Care Inc.
Conditions:
New York Medical Marijuana Program Qualifying Conditions
Eligibility:
All Genders
18+ years
Brief Summary
The primary purpose of this research is to identify genetic factors that may affect the efficacy and safety of medical marijuana, regardless of condition. The pharmacogenomics test detects DNA variant...
Detailed Description
This observational, population-based study will examine genetic differences between ultra-rapid, intermediate and poor metabolizers of various formulations of Columbia Care's medical cannabis products...
Eligibility Criteria
Inclusion
- Males and Females age 18 and older
- Currently obtaining medical marijuana products from Columbia Care LLC
- Willing to participate and consent to a DNA analysis
- Purchased product from Columbia Care for three consecutive encounters spanning a 6-month period
Exclusion
- Unwillingness to participate and consent to a DNA analysis
- Unwillingness to answer a survey/questionnaire on patient satisfaction as related to product efficacy
Key Trial Info
Start Date :
July 11 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 30 2020
Estimated Enrollment :
157 Patients enrolled
Trial Details
Trial ID
NCT04083261
Start Date
July 11 2019
End Date
March 30 2020
Last Update
July 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia Care New York Dispensary
New York, New York, United States, 10003